Please assess the completion status of the following clinical trial:

Trial Title: Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \<18 years~* myeloablative conditioning and autologous or allogeneic stem cell transplantation with at least one of the following risk factors for VOD:~  1. Pre-existing liver disease~ 2. Second myeloablative HSCT~ 3. History of treatment with gemtuzumab ozogamicin (MYLOTARGÒ, GO, CMA-676, Wyeth)~ 4. Allogeneic HSCT for leukemia beyond the second relapse~ 5. Osteopetrosis (OP)~ 6. Conditioning with busulfan and melphalan~ 7. Macrophage activating syndromes (MAS, like hemophagocytic lymphohistiocytosis, Griscelli, Chediak-Higashi~ 8. Adrenoleukodystrophy (ALD)~Exclusion Criteria:~* Pregnant patients~* Patients who are transplanted but do not fulfill any of the above mentioned criteria

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Prophylaxis Arm (Type: EXPERIMENTAL): None
- Control Arm (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).